Recruiting

Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers

NCT03976999 · Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title

Development of a Prospective and Monocentric Cinical and Biological Database in Epithelial Ovarian Cancer, Fallopian Tube Cancer and Primitive Peritoneal Cancer

About this study

A Clinical and Biological Database is a collection of reliable, prospective and representative datas. This collection, provided to the scientific community, will help to develope research programs such as : * Cinicals and biological predictive factors of treatments response * Identification of biological tumoral markers associate with survival * Identification of prognosic factors after recidivism * Diagnostics tests optimisation and follow-up from blood samples ( Circulating Tumor Cells (CTC) ) * Developing strong preclinical models. Those models would be later used to test alternative treatments and would help to identify new biomarkers

Eligibility criteria

Inclusion Criteria: * 18 or older * Patient at the diagnosis of an epithelial ovarian cancer, or a fallopian tube caner or a primitive peritoneal cancer * Patient eligible for, at least, one surgery and a chemotherapy * Patient having given his informed, written and express consent Exclusion Criteria: * Patient not affiliated to a social protection scheme * Pregnant and / or nursing women * Subject under tutelage, curatorship or safeguard of justice * Patient whose regular follow-up is impossible for psychological, familial, social or geographical reasons

Study design

Enrollment target: 300 participants

Allocation: na

Masking: none

Age groups: adult, older_adult

Timeline

Starts: 2017-07-05

Estimated completion: 2032-07

Last updated: 2025-02-12

Interventions

Other: Biological collection

Primary outcomes

• Proportion of patients who gave their consent to participate in the study (Until the study completion : 3 years)

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle · other

Contacts & investigators

ContactAurore MOUSSION · contact · DRCI-icm105@icm.unicancer.fr · +33 4 67 61 31 02

InvestigatorCOLOMBO Pierre-Emmanuel, M.D · principal_investigator, ICM - Institut régional du Cancer Montpellier

All locations (1)

ICM - Institut régional du Cancer MontpellierRecruiting

Montpellier, France

View on ClinicalTrials.gov ↗Find similar trials